comparemela.com

Latest Breaking News On - Jagsonpal pharmaceuticals limited - Page 1 : comparemela.com

Jagsonpal Pharmaceuticals Ltd posts Rs 7 47 crore PAT in Q2 FY24

Jagsonpal Pharmaceuticals Ltd posts Rs 7 47 crore PAT in Q2 FY24
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Jagsonpal pharmaceuticalsJagsonpal pharmaceuticals ltdPharmaceuticals limitedHalf year endedJagsonpal pharmaceuticals limited

Doon police arrest two men on charges of selling spurious medicines in several states

The Dehradun police have arrested two men on charges of manufacturing spurious medicines and supplying them across the country. The police conducted raids at the accused s premises in Haridwar and Dehradun and seized about 30 lakh spurious medicines and equipment worth lakhs of rupees besides

Ajai singhSachin sharmaDehradun aman viharVikram rawatJagsonpal pharmaceuticalsNaman viharJagsonpal pharmaceuticals limitedDoon police arrest two men on charges of selling spurious medicines in several states

Jagsonpal Pharmaceuticals Ltd Q1 FY2024 PAT up at Rs 7 47 crore

Jagsonpal Pharmaceuticals Ltd Q1 FY2024 PAT up at Rs 7 47 crore
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Jagsonpal pharmaceuticalsJagsonpal pharmaceuticals ltdPharmaceuticals limitedJagsonpal pharmaceuticals limited

Jagsonpal Pharmaceuticals Ltd recommends dividend of Rs 5

The Board of directors of Jagsonpal Pharmaceuticals Limited has recommended a dividend of Rs. 5/- per equity share for the financial year ended March 31, 2023.

Jagsonpal pharmaceuticalsJagsonpal pharmaceuticals ltdJagsonpal pharmaceuticals limited

Jagsonpal Pharmaceuticals Ltd Q4 FY2023 PAT slips QoQ to Rs 5 60 crores

The Board of Directors of Jagsonpal Pharmaceuticals Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2023 - Q4FY23 and FY2023.

Jagsonpal pharmaceuticals ltdJagsonpal pharmaceuticalsPharmaceuticals limitedYear endedFinancial yearJagsonpal pharmaceuticals limited

vimarsana © 2020. All Rights Reserved.